Search Results for "Trial Watch Hodgkin S Lymphoma Progress"
Matching Channels
Hodgkin Lymphoma is a disorder caused by malignant proliferation of lymphocytes, which contain characteristic mirror-image nuclei (Reed-Sternburg cells). The resulting lymphadenopathy can be l...
Lymphoma is a cancer of the lymph nodes; classified as Hodgkin or non-Hodgkin lymphoma. Malignancy varies, and the prognosis can be from a few months to many years. Symptoms include enlarged lymph...
CD30, also known as TNFRSF8, is a cell membrane protein of the tumor necrosis factor receptor family and tumor marker. This receptor is expressed by activated, but not by resting, T and B cells. It...
Matching News
Progress Achieved in Reducing Radiation for Pediatric Hodgkin Lymphoma Treatment
Investigators have succeeded in keeping cure rates high for young patients with favorable-risk Hodgkin lymphoma while reducing their risks...
[Seminar] Non-Hodgkin lymphoma
Lymphomas are solid tumours of the immune system. Hodgkin's lymphoma accounts for about 10% of all lymphomas, and the remaining 90% are referred to as non-Hodgkin lymphoma. Non-Hodgkin lymphomas have...
Lymphoma: More a Question of Toxicity Than Efficacy
Drs. Bruce Cheson and Gilles Salles discuss provocative studies in Hodgkin lymphoma and non-Hodgkin lymphoma presented at ASCO® 2012. Medscape Hematology-Oncology
Pediatric Hodgkin lymphoma can be treated without radiation and intensive chemotherapy
A multicenter trial showed that nearly half of young patients with early-stage Hodgkin lymphoma can be cured without undergoing either irradiation or intensive chemotherapy that would leave them at ri...
Some Children with Hodgkin Lymphoma May Not Need Radiation Therapy
Children with Hodgkin lymphoma who have favorable clinical features and who respond early to chemotherapy may not need treatment with radiation. The finding, reported in the June 27 JAMA, is from a cl...
A multicenter trial showed that nearly half of young patients with early-stage Hodgkin lymphoma can be cured without undergoing either irradiation or intensive chemotherapy that would leave them at ri...
Hodgkin’s lymphoma drug to launch soon
Brentuximab vedotin is due to be launched next week (19 November 2012) for the treatment of relapsed or refractory Hodgkin’s lymphoma...
- 96 Percent Complete Remission Rate in Newly Diagnosed Hodgkin Lymphoma Patients Treated with ADCETRIS in Combination with AVD Chemotherapy - - Safety and Response Data Support Ongoing Phase III Tria...
Matching PubMed Articles
Trial watch: Hodgkin's lymphoma progress.
Primary Orbital Manifestation of Hodgkin Lymphoma in a 3-Year-Old Child.
Hodgkin lymphoma is exceedingly rare in children, as is primary orbital manifestation of systemic Hodgkin lymphoma in any age category. The authors describe the clinicopathologic manifestations of a r...
Abstract The aim of this study was to determine the prognostic significance of the expression of Lyn, Fyn and Syk in Hodgkin lymphoma and its correlation with Epstein?Barr virus (EBV) infection. With...
Detection of Hodgkin lymphoma within ovarian tissue.
OBJECTIVE: To describe the detection of Hodgkin lymphoma within ovarian tissue taken at the time of harvest for cryopreservation. DESIGN: Case report. SETTING: University-affiliated women's hospital....
